fluids and electrolytes mohammad ruhal ain r ph, pgdpra, m pharm (clin. pharm) department of...
TRANSCRIPT
![Page 1: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/1.jpg)
Fluids and
Electrolytes
Mohammad Ruhal AinR Ph, PGDPRA, M Pharm (Clin.
Pharm)Department of Clinical Pharmacy
Pathophysiology 2
![Page 2: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/2.jpg)
Case Study 1
A 65-year-old man with a 3-day history of temperature to 102°F, lethargy, and productive cough is hospitalized for community-acquired pneumonia. •His medical history includes hypertension and coronary artery disease. • His vital signs include HR 104 beats/minute, BP 112/68 mm Hg, and temperature 101.4°F. His weight is 80 kg, decreased skin turgor, urine output 10 mL/hour, BUN 16, Cr 1.5 mg/dL, and WBC 10.4. Other laboratory values are normal.
![Page 3: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/3.jpg)
Subjective and objective for this patient are?
Subjective:
Objective:
![Page 4: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/4.jpg)
Question:
What do you think this patient has ? I. Volume overload II. Volume depletion III. None of the aboveIV. Both
![Page 5: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/5.jpg)
![Page 6: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/6.jpg)
Question:
What do you think this patient has ? I. Volume overload II. Volume depletion III. None of the aboveIV. Both
![Page 7: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/7.jpg)
• Signs (like HR and BP) in patient with Intravascular Volume Depletion improved after a 500- to 1000-mL fluid bolus
[T] [F] •Tachycardia is the earliest sign of
volume depletion [T] [F]
True and False Questions
![Page 8: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/8.jpg)
Restore intravascular volume and prevent organ hypoperfusion. Fluid resuscitation is indicated for patients with signs or symptoms of intravascular volume depletion.
What’s the goal of therapy in this patient ?
![Page 9: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/9.jpg)
• A 72-year-old woman , weight 60 kg , with a history of hypertension has after starting hydrochlorothiazide she experiences dizziness, fatigue, and nausea. 3 weeks earlier. Her serum Na+ is 116 mEq/L K+ is 4 mEq/L, BP is 86/50 mm Hg, and HR is 122 beats/minute.
Case Study 2
![Page 10: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/10.jpg)
Question:This patient has I. Hypernatremia, hypervolemia II. Hyponatremia , hypovolemia III. Hyponatremia, hypervolemia
Sodium : 135–145 mEq/L Potassium : 3.5–5.0 mEq/L
![Page 11: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/11.jpg)
Question:This patient has I. Hypernatremia, hypervolemia II. Hyponatremia , hypovolemia III. Hyponatremia, hypervolemia
This patient has (tachycardia, Hypotension )… hypovolemia Serum Na+ … low (hyponatremia)
![Page 12: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/12.jpg)
![Page 13: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/13.jpg)
• A 72-year-old woman , weight 60 kg , with a history of hypertension has after starting hydrochlorothiazide she experiences dizziness, fatigue, and nausea. 3 weeks earlier. Her serum Na+ is 116 mEq/L K+ is 4 mEq/L, BP is 86/50 mm Hg, and HR is 122 beats/minute. Question: This patient has symptoms of hyponatremia and it appears after what level ? I.< 130 mEq/L II.<140 mEq/L III.<120 mEq/L
![Page 14: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/14.jpg)
Question: This patient has symptoms of hyponatremia and it appears after what level ? I.< 130 mEq/L II.<140 mEq/L III.<120 mEq/L Malaise: general feeling of discomfort
Obtundation: altered level of consciousness
![Page 15: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/15.jpg)
Question: The cause of hyponatremia is HCT (hydrochlorothiazide) ? (T/F)
![Page 16: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/16.jpg)
A 40-year-old man has been admitted to the hospital after several days of vomiting and diarrhea. In the emergency department, he had several runs of non-sustained ventricular tachycardia. His plasma K+ on admission was 2.8 mEq/L. After receiving 200 mEq of potassium chloride (KCl) infused over 24 hours, his repeat K+ is 3.2 mEq/L, and he continues to have runs of ventricular tachycardia.
Case Study 3
![Page 17: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/17.jpg)
Other laboratory findingsinclude Na+ 143 mEq/L, magnesium 1.1 mEq/L, phosphorus 3 mg/dL, Ca++ 9 mg/dL, and ionized Ca++ 1.1 mmol/L.
![Page 18: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/18.jpg)
What information (signs, symptoms, laboratory values) indicates the presence and severity of the electrolyte abnormalities? ( SOAP )
![Page 19: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/19.jpg)
Subjective: vomiting and diarrhea
Objective: he had several runs of nonsustained ventricular tachycardia. plasma K+ on admission was 2.8 mEq/L. include Na+ 143 mEq/L, magnesium 1.1 mEq/L, phosphorus 3 mg/dL, Ca++ 9 mg/dL, and ionized Ca++ 1.1 mmol/L.
Assessment: Based on clinical presentation and lab values This patient has hypokalemia that’s resistant to the conventional treatment
Plan?
![Page 20: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/20.jpg)
a. Reduced intake seldom causes hypokalemia because renal excretion is minimized
because of increased renal tubular absorption.
b. Increased shift of K+ into cells can occur with the following:
i. Increased pH ii. Insulin or a carbohydrate load iii. β2-Receptor stimulation caused by
stress-induced epinephrine release or administration of a β-agonist (e.g., albuterol, dobutamine)
iv. Hypothermia
The cause of hypokalemia in this case ?
![Page 21: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/21.jpg)
c. Increased GI losses of K+ can occur with vomiting, diarrhea, intestinal fistula or enteral tube drainage, and chronic laxative abuse.
d. Increased urinary losses can occur with
mineralocorticoid excess and diuretic use (e.g., loop and thiazide type). ( common cause )
e. Hypomagnesemia is commonly associated
with hypokalemia caused by increased renal loss of K+; correction of plasma K+ requires simultaneous correction of serum magnesium.
![Page 22: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/22.jpg)
Complete the following sentences
Regarding symptoms of mild hypokalemia ( 3.5-3 mEq/L) patient is ……………..……………( symptomatic / asymtomatic )
Regarding symptoms of moderate hypokalemia ( 3- 2.5 mEq/L) ) patient may complain of symptoms include …………………………………………. . Patient with severe hypokalemia ( <2.5 mEq/L) can have ……………………………. (signs ,symptoms )
![Page 23: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/23.jpg)
Complete the following sentences
Regarding symptoms of mild hypokalemia ( 3.5-3 mEq/L) patient is ……………..……………( symptomatic / asymtomatic )
Regarding symptoms of moderate hypokalemia ( 3- 2.5 mEq/L) ) patient may complain of symptoms include …………………………………………. .
Patient with severe hypokalemia ( <2.5 mEq/L) can have ……………………………. (signs ,symptoms )
ANSWER: cramping, weakness, malaise, and myalgias
ANSWER Musculoskeletal: Cramping and impaired muscle contraction.
![Page 24: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/24.jpg)
What type of hyperkalemia this patient has ?
I. Mild hypokalemia
II. Moderate hypokalemia
III. Severe hypokalemia
![Page 25: Fluids and Electrolytes Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department of Clinical Pharmacy Pathophysiology 2](https://reader035.vdocuments.net/reader035/viewer/2022062308/56649dc75503460f94abb6e9/html5/thumbnails/25.jpg)
What type of hyperkalemia this patient has ?
I. Mild hypokalemia
II. Moderate hypokalemia
III. Severe hypokalemia